Covid-19 News

    UArizona Cancer Center Study Indicates Cancer Patients on Chemo Many Times Don’t Receive Full Protection from COVID-19 Vaccine


    UArizona Cancer Center Study Indicates Cancer Patients on Chemo Many Times Don’t Receive Full Protection from COVID-19 Vaccine
    A recent study led by the University of Arizona Health Sciences investigated whether cancer patients receiving chemotherapy face additional risks with the
    trialsitenews.com


    A recent study led by the University of Arizona Health Sciences investigated whether cancer patients receiving chemotherapy face additional risks with the COVID-19 vaccine. Led by Rachna Shroff, chief of gastrointestinal medical oncology at the UArizona Cancer Center and director of the Cancer Center Clinical Trials Office, and a team of UArizona Health Sciences researchers, the study team found that 53 cancer patients receiving chemotherapy didn’t have the level of protection from the two-dose COVID-19 regimen as the treatment inhibits their immune response. However, at least in this study, a third dose mitigated the problem, raising immune response to combat SARS-CoV-2.


    Results of this study were recently published in the prestigious peer-reviewed journal Nature.


    Interdisciplinary Approach to Studies

    The UArizona Health Science showcased an interdisciplinary and collaborative approach to the study, which facilitated efficiency from start to completion. Dr. Shroff declared, “The fact that we could answer this question in such a short time speaks to what can happen when you leverage the varied expertise we have within UArizona Health Sciences.”


    Note that Dr. Shroff is a member of the BIO5 Institute. Launched in 2001 at the University of Arizona, this center connects and mobilizes hundreds of world-class plant, animal, and human bio-scientists, as well as engineers, physicians, and computational researchers to develop creative solutions for complex challenges such as disease, hunger, water, and food safety, and other health issues facing Arizona.


    UArizona Accelerates Study

    The interdisciplinary research team was formed not long after the Pfizer vaccine was approved in late 2020. The focus of the study was patients with solid tumors, such as breast or gastrointestinal cancer, and people on immunotherapy were excluded. Dr. Shroff reported, “Cancer Center clinicians went above and beyond to enroll their patients in the study because we all had a unified goal to protect our patients.”


    The Study

    University of Arizona News reported that this study compared the immune response after the first and second dose of the Pfizer COVID-19 vaccine with those of 50 healthy adults. After two vaccine doses, most of the cancer patients showed some immune response to the vaccine, meaning they had antibodies for SARS-CoV-2, the virus that causes COVID-19.


    The Findings

    Another participating co-investigator, Deepta Bhattacharya, reported, “We were pleasantly surprised.” The professor of immunobiology in the College of Medicine—Tucson, also a member of the BIO5 Institute, continued, “We looked at antibodies, B cells and T cells, which make up the body’s defense system, and found the vaccine is likely to be at least partially protective for most people on chemotherapy.” But this response was lower than the average response in healthy adults. In fact, a few of the participants had no response to the COVID-19 vaccine, indicating in some cases, they had no immunization benefits. However, after receiving a third booster shot, 20 of the study’s participants had a positive immune response—much like what the average healthy person would experience after two doses.


    UArizona Health Sciences

    UArizona Health Sciences has campuses in Tucson and Phoenix and represents one of the top-ranked academic medical centers in the Southwest. UArizona Health Sciences includes the College of Medicine-Phoenix, College of Medicine-Tucson, College of Nursing, College of Pharmacy, and the Mel and Enid Zuckerman College of Public Health. In addition, 12 UArizona Health Sciences centers and programs focus on cancer, neurodegenerative diseases, pain and addiction, and respiratory diseases; biomedical informatics, health technology innovation and simulation training; and precision health care and health disparities. A leader in next-generation education, biomedical research, and public outreach, UArizona Health Sciences employs nearly 5,000 people, has approximately 4,000 students and 900 faculty members, and garners more than $200 million in research grants and contracts annually. Important background information can be found here.


    UArizona includes the “Cancer Center,” one of the 51 comprehensive cancer centers across America backed by the National Cancer Institute (NCI), and part of the National Institutes of Health (NIH). Designation as Comprehensive Cancer Center represents the NCI’s highest designation. The Clinical Trials Office (CTO) oversees and conducts many clinical trials at UArizona Cancer Center.


    Dedicated to advancing high-quality clinical trial research in accordance with the University of Arizona Cancer Center’s educational, research, clinical care, and community service mission, the CTO is responsible for the administrative, regulatory, and institutional requirements to establish and conduct clinical research at the University of Arizona Cancer Center which is supported through contracts with private industry and other entities.


    The CTO serves as a central resource for the University of Arizona faculty, staff, and departments involved in cancer clinical trials research, as well as sponsors seeking to conduct cancer clinical trials at the University of Arizona Cancer Center.


    Research Investigators

    Rachna Shroff, MD chief of gastrointestinal medical oncology at the UArizona Cancer Center and director of the Cancer Center Clinical Trials Office


    Deepta Bhattacharya, Ph.D. professor of immunobiology in the College of Medicine—Tucson, Cancer Biology Program


    Coauthors include Dr. Pavani Chalasani, associate professor of medicine in the Cancer Center; Bonnie LaFleur, biostatistics research professor in the BIO5 Institute; Dr. Michael D. Dake, senior vice president of UArizona Health Sciences; Dr. Aaron J. Scott, associate professor of medicine; Dr. Janko Nikolich-Žugich, head of the Department of Immunobiology; Michael Worobey, head of the Department of Ecology and Evolutionary Biology; Ryan Sprissler, manager of the University of Arizona Genetics Core; research assistant professor Mladen Jergovic; associate research scientist Jennifer L. Uhrlaub; postdoctoral researcher Marta V. Schoenle; graduate students Grace Quirk and Tyler J. Ripperger; research assistant Shelby Dalgai; research specialist Alexander Wolf; clinical research coordinator Hytham Hammad; Cancer Center program manager Daniel Pennington; research nurse Amy Carrier; and research technician Ran Wei.


    Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine
    Cancer Center researchers found lower immune response to the COVID-19 vaccine in patients on active chemotherapy. A third dose of the Pfizer vaccine boosted…
    news.arizona.edu


    Radiation treatment also has a bad effect on vaccination. I don't need a study to confirm that. My wife shows no antibodies after JJ and a Moderna booster. 2 time breast cancer survivor. She now takes 350mg of Sutherlandia a day and a prescribed dose of calcidiol. Both recommended and prescribed by her oncologist.

    I've heard of IgG, IgA, IgE, IgM and IgD. Never heard of IgN and IgS.

    Quote from THHuxleynew

    I think W needs to view this. It is a useful video.


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

    That video didn't age well.

    Quote from Fm1

    In August, 39 vials of the Moderna vaccine in Japan were found to be contaminated with metal. Shortly after, black and pink substances were spotted in syringes and vials of the vaccine in a vaccination center of Okinawa and Gunma. After these reports, Japan suspended the use of Moderna vaccines, recalled 1.6 million vaccines, and signed a replacement deal with Novavax. Some 3,790 shots from that batch had been administered before these contaminants were discovered. As TrialSite recently reported, deaths occurred in at least two patients after receiving their second doses from this batch, and the cause is being investigated by the Ministry of Health, Labor and Public Welfare (MHLW), Japan. However, though the vaccines belonged to the same batch, they did not belong to the lots that had rubber or metal contaminants in them.

    In September, 95 vials of unused Pfizer vaccine in Japan were found to have floating contaminants, five of which had already been distributed to vaccination clinics. After visual inspection of the remaining vials from the same batch, the officials of Japan gave them the all-clear as there was no visible sign of contamination.

    I wonder what 'visual inspection' entails. Visual inspection under a microscope? I've seen videos from multiple labs around the world, including the US, which find very strange things under the microscope when observing vaccine contents. Also strange things in the blood and the look and arrangement of blood cells of those recently vaccinated and who are experiencing adverse effects.

    The true criminal behavior is industry insiders ignoring the treads in the vaers data bases from around the world. Not just ignoring but in some cases spinning effects as normal and to be expected. You seem to be one of those insiders Thomas, but that's just my opinion.

    Quote from gerold.s

    Thanks for your posting with evidence from an other part of the world. If you find such evidence in Germany AND Japan, it could well appear somewhere else and I would call it "universal".
    So it seems even the manufacturing process is experimental.

    As long as they check the final products for contamination, this is no threat. Unfortunately, in Japan a few doses slipped past the final check. That is not likely to happen again.


    There can be problems with the manufacturing of any product. Semiconductors manufacturing is the most careful type, with the cleanest environment and the best control, yet there are occasionally problems with contamination.


    Yesterday, WalMart sent me an e-mail as follows. It is a little creepy that they are keeping track of what I buy. There is nothing "experimental" about the manufacturing of Lotrimin, but it was contaminated.


    We have been notified that Bayer Healthcare has initiated a Recall of Various Lotrimin and Tinactin products due to the presence of benzene.


    Our records reflect that you may have purchased one or more of the below items since 09/01/2018:


    Product Description

    UPC

    Affected Date Codes

    Lotrimin Spray Liquid Value Size 4.6 oz

    4110040788

    All Date Codes

    Lotrimin Daily Prevention Powder Spray 5.6 oz

    4110058720

    Lotrimin Bundle

    4110059075

    Tinactin Deodorant Spray Powder Super-Size 4.6 oz

    31101741000

    Tinactin Spray Liquid Super-Size 5.3 oz

    31101741005


    Quote from Fm1

    The true criminal behavior is industry insiders ignoring the treads in the vaers data bases from around the world.

    If you really think so, you do not understand the first thing about statistics. I strongly recommend you read a junior high level textbook before commenting. You are innumerate. We have been over the reasons VAERS shows no fatalities many times. See, for example:


    Fact Check-VAERS data does not prove thousands died from receiving COVID-19 vaccines
    Updated to correct repeated clause and quotation in paragraph 12.
    www.reuters.com

    Quote from Mark U

    I wonder what 'visual inspection' entails.

    It means look at the sample with the naked eye. It is an essential final step in any protocol to avoid contamination in a vaccine. ALWAYS look before you administer a dose. The same goes for a pill, lotion, or any kind of food. Always look. For most kinds of meat and fish, you should also always smell the sample. The human sense of smell is remarkably sensitive. Not as good as a dog's, but still remarkable. When semiconductors were first developed in the 1950s, a researcher smelled some sulphur which turned out to be an important ingredient in a successful batch. It was there in trace amounts.

    Quote from JedRothwell

    If you really think so, you do not understand the first thing about statistics. I strongly recommend you read a junior high level textbook before commenting. You are innumerate. We have been over the reasons VAERS shows no fatalities many times. See, for example:


    https://www.reuters.com/articl…19-vaccines-idUSL1N2LV0NY

    You surely do not keep up with your reading, just yesterday a woman was confirmed to die from the j&j in Washington st. And 4 more are under investigation. It would seem that it's you who needs that Jr. High update.

    Or maybe you are back to being the CDC propaganda minister.

    Quote from Fm1

    You surely do not keep up with your reading, just yesterday a woman was confirmed to die from the j&j in Washington st. And 4 more are under investigation.

    That has NOTHING remotely to do with your assertion that the CDC and others are covering up VAERS data. Nothing! Seriously, you do not understand the fundamentals. Obviously there will be some adverse effects and even deaths when billions of vaccines are administered. When billions of people eat grapes, or a few grams of salt, there will be adverse effects. Everyone knows that the J&J vaccine has caused some deaths. It is slightly more dangerous than the mRNA vaccines. As far as anyone knows, the mRNA vaccines have caused at most 1 death, in New Zealand. However, a handful of deaths from the J&J adenovirus vaccines is not a valid reason to stop giving it. All vaccines and all drugs of every type cause a certain number of deaths. Even things like aspirin. The benefits far outweigh the costs, so we continue to use aspirin.


    The CDC is not covering up anything. The whole point of VAERS is to reveal possible problems. The CDC says that VAERS has documented 8,164 deaths associated with the COVID vaccines. It also says that when experts carefully examined medical reports from these events, they concluded that all of the deaths were coincidental. The number of deaths is what you would expect by coincidence, so this is not surprising.


    It is not possible to establish with certainty the number of people killed by COVID vaccines. You can only estimate this. It is not possible to know whether any of the 8,164 reported deaths in the U.S. were not coincidental after all. There are unknowns and there is a margin of error in all data. However, the best estimate made by experts is that no deaths have resulted from the mRNA vaccines in the U.S. That estimate is light years ahead of the bullshit from anti-vaccine nitwits at TrialSiteNews, FOX News, or Wyttenbach.


    COVID-19 Vaccination
    COVID-19 vaccines protect against COVID-19. Get safety info and more.
    www.cdc.gov


    • Reports of death after COVID-19 vaccination are rare. More than 390 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through September 27, 2021. During this time, VAERS received 8,164 reports of death (0.0021%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines. However, recent reports indicate a plausible causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS, a rare and serious adverse event—blood clots with low platelets—which has caused deaths pdf icon[1.4 MB, 40 pages].

    More CDC propaganda? A death is a stat to you and the death cult, while a death to me is a loss for humanity. You don't seem to have a soul Mr rothwell!

    Quote from JedRothwell

    All vaccines and all drugs of every type cause a certain number of deaths. Even things like aspirin. The benefits far outweigh the costs, so we continue to use aspirin.

    As it happens, a professor named Rothwell estimates that aspirin and other antiplatelet drugs kill 3,000 people a year in the U.K. That is not a valid reason to stop using aspirin. It is orders of magnitude more people than are killed by all types of COVID vaccines worldwide.


    Risk of bleeds and death with daily aspirin use higher than thought
    Research suggests 3,000 people die a year in UK from long-term use of aspirin or similar drugs, but also taking heartburn medication could help reduce risk
    www.theguardian.com


    QUOTE:


    "Around 40% of adults aged 75 or over in the UK take a daily aspirin and lifelong treatment is recommended for patients who have previously had a heart attack or stroke.

    The preventative effects are well-established in people who have suffered a major heart event, reducing the risk of another by 20%.

    But Prof Peter Rothwell, from Oxford University and the lead author of the study, said there are about 20,000 major bleeds and around 3,000 deaths caused by aspirin or other antiplatelet drugs each year. . . ."

    Quote from Fm1

    More CDC propaganda? A death is a stat to you and the death cult, while a death to me is a loss for humanity.

    Oh give me a break. How about 2,000 deaths a day in the U.S., nearly all of them preventable with the vaccine? That doesn't bother you?


    Do you not understand the concept of risk/benefit analysis?!? Do you not see that a slight risk of death from the J&J adenovirus vaccine is far outweighed by the number of lives saved by that vaccine? Are you really so stupid and ill educated you never learned this? The number of people killed by aspirin is far outweighed by the number who are saved, not to mention the benefit of billions of headaches and muscular pain cured by aspirin. Contaminated fish sicken millions of people, and kill thousands. Do you think we should stop eating fish? Even if that means hundreds of thousands of people starve?


    If you go out for a walk, you might be run over by a bus. You might be stung by a bee and die from anaphylactic shock. Bees are the most dangerous animals in North America. So, are you going to stay in bed all day with the lights turned out? Avoiding any possible risk? Obviously, staying in bed all day would be far more risky than bees and buses!


    What you say has no logic at all. You are, as I said, innumerate. Or you are bullshitting us, and you understand perfectly well that everything we do has some risks, but also benefits that far outweigh the risks.

    Quote from JedRothwell

    Do you not understand the concept of risk/benefit analysis?!? Do you not see that a slight risk of death from the J&J adenovirus vaccine is far outweighed by the number of lives saved by that vaccine? Are you really so stupid and ill educated you never learned this? The number of people killed by aspirin is far outweighed by the number who are saved, not to mention the benefit of billions of headaches and muscular pain cured by aspirin

    If FM1 does not understand this simple concept -- that the benefits and lives saved by the vaccines far outweigh the dangers from vaccines -- then he is a complete ignoramus and he should not take part in any scientific discussion. It is astounding to me that any adult would not understand these things. Any child over age 8 should understand these things!


    If FM1 really is this stupid it is no wonder he keeps posting the outrageous nonsense published by TrialSiteNews. I thought he was doing that as a service to warn us about the latest garbage from the antivaxxers, but perhaps he thinks this garbage has some scientific validity.

    Quote from THHuxleynew

    I'd bet it is the same Japanese batches that have been recalled and were highly advertised.

    One Japanese problem at the end was a syringe rubber failure.... So such discussions are not worth following. Except that it points to bad manufactoring practice if it happens to often.

    Quote from Fm1

    Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

    This is not the real problem. This drug will kill 50x more people than giving Ivermectin would do. So its fascist medicine....

    Quote from Fm1

    The great tragedy is that, after their great success,

    This communication is even more criminal than selling this drug. The Merck-Vectin odds reduction is just 6%... It totally failed in the hospital setup!

    Quote from JedRothwell

    VAERS received 8,164 reports of death (0.0021%) among people who received a COVID-19 vaccine.

    Compared this to the same amount of flu vaccine --> > 1000x increase. And VERS maximally contains 1/10 of all deaths.

    Quote from JedRothwell

    But Prof Peter Rothwell, from Oxford University and the lead author of the study, said there are about 20,000 major bleeds and around 3,000 deaths caused by aspirin or other antiplatelet drugs each year. . . ."

    And so far no deaths from Ivermectin. That's why we can treat everybody more or less blindly.

    Large Observational Study: Pfizer’s COVID-19 Vaccine Loses Effectiveness to Prevent Infection & Transmission


    Large Observational Study: Pfizer’s COVID-19 Vaccine Loses Effectiveness to Prevent Infection & Transmission
    Kaiser Permanente Southern California, a division of one of the nation’s largest healthcare systems, recently concluded and published the results of a
    trialsitenews.com


    Kaiser Permanente Southern California, a division of one of the nation’s largest healthcare systems, recently concluded and published the results of a large retrospective cohort study involving the health records of 3,436,957 people aged 12 and up. Sponsored by Pfizer, the researchers at Kaiser Permanente Southern California investigated the effectiveness of the Pfizer mRNA-based vaccine (BNT162b2) against SARS-CoV-2 and associated COVID-19 hospital admissions for up to half a year—a study duration from December 14, 2020, to August 8th, 2021. With the results published in the prestigious Lancet, the investigators pointed to data indicating a decline in Pfizer-BioNTech vaccine performance when it comes to preventing Delta variant-based infection. In other words, the ability of this vaccine product to protect against SARS-CoV-2 infection diminishes, although that reality hasn’t made its way to the mainstream media—yet. Recent data from Project Salus and the Vermont Department of Health indicate potential challenges with breakthrough hospitalizations. Regardless, the data herein points to Pfizer’s push for a bi-annual “COVID-19 shot.”


    The Study

    Disclosed in Clinicaltrials.gov (NCT0484854), this large retrospective observational study sought to determine the vaccine effectiveness of the standard 2-doses of BNT162b vaccine against COVID-19 associated hospitalization. They evaluated fully vaccinated defined as receiving 2 doses with at least 7 days after the second dose, and partially vaccinated, defined as at least 14 days after 1 dose or 2 doses with less than 7 days after the second dose. The study team also sought to better understand how well the vaccine is protecting people from emergency department admissions, ICU admissions, outpatient visits, and death.


    The Kaiser Permanente-led research team designed a large retrospective database study using two parallel study designs, including A) a test-negative case-control design and B) a retrospective cohort design. The first design aims to assess vaccine effectiveness against COVID-19 hospitalization (primary endpoint) and emergency department (ED) admission. The retrospective cohort’s purpose is to assess vaccine effectiveness against COVID-19 hospitalization (primary), ICU admission, death, ED admission, and outpatient disease (e.g., with no subsequent hospitalization within 14 days).


    Findings

    The results of this study indicate the frailty of this vaccine as the protection afforded by it markedly declines by month sixth—several other observational studies have come to similar conclusions.


    The study authors controlling for confounders (e.g., prior infection) compared fully vaccinated and unvaccinated and determined that BNT162b2 effectiveness against SARS-CoV-2 infection dropped from 88% (95% CI, 86-89%) during the first-month post the second jab (fully vaccinated) to 47% (43-51%) after five months from the last dose.


    Probing for effectiveness against the Delta variant, the authors concluded that after the first month of full vaccination, effectiveness equals a solid 93% (85-97%) however, that protection plunges to 53% (39-65%) after just four (4) months from the second dose. Other variants were analyzed for purposes of BNT162b effectiveness. The authors at Kaiser Permanente reported that after one month, a fully vaccinated 97% (95-99%) effectiveness was achieved; however, that number rapidly dropped to 67% (45-80%) by month four to five.


    While the authors reported a continued high overall protection rate (93% [95% CI 84–96]) against hospital admission due to Delta variant-based SARS-Cov-2 across all ages for up to six (6) months, other observational studies and real-world reports suggest growing breakthrough hospitalization.


    However, for the purpose of this study, the authors wrote that during the six-month duration of the study, the ability of the vaccine to keep SARS-CoV-2 infected people out of the hospital persists.


    Limitations

    Like all studies, this Pfizer-funded endeavor included limitations faced by the investigators. TrialSite summarizes those limitations here.


    · Authors were not able to establish causal relationships between vaccination and COVD-19 outcomes in the study


    · Real-world studies such as this one make it difficult to achieve “a perfect balance of testing patterns and other characteristics between vaccinated and unvaccinated patients.”


    · No sufficient data to ensure the appropriate following of masking guidelines, social interactions, and occupation, which may also impact likelihood of testing for SARS-CoV-2 when one experiences symptoms or routinely as preventive measure


    · Vaccine effectiveness estimates targeting SARS-CoV-2 infection as well as hospital admission “could be muted by mild or asymptomatic infections and are not directly comparable to estimates of effectiveness against symptomatic disease.”


    · The authors note that sequencing failed more often in association with samples from vaccinated people—associated with lower viral loads


    Conclusion

    It’s all in the point of view, suggests TrialSite. The authors herein interpreted the results to showcase the great success of the mass vaccination program now underway across the United States and around the world.


    BNT162b2 is not stopping breakthrough infections, with significant degradation in vaccine performance after month three (3) and especially after month four (4). This leads to viral transmissibility as the vaccines are not stopping the vaccinated from becoming vectors, serving to spread the pathogen, especially if the Delta variant is involved.


    On the other hand, for a solid six months, the data indicates that BNT162b2 protects against hospitalization and death. Yet mounting data from other unpublished real-world studies point to mounting data points indicating a greater risk of breakthrough infections as exhibited recently by Project Clarus, Vermont Department of Health Data, and Public Health England.


    TrialSite will continue to monitor the studies and report on the findings in an objective and unbiased manner.


    The Research Center

    Kaiser Permanente, Department of Research Evaluation, Southern California, conducted this study. Embedded within Kaiser Permanente’s large and dynamic health care system, this division operates in the heavily populated and diverse Southern California.


    Kaiser Permanente’s Southern California research program includes 40+ scientists, 400 research and support staff, and 250 physician investigators. At present, Kaiser Permanente Southern California manages 1,250 active study protocols, including 400+ clinical trial protocols. Researchers from this division of Kaiser Permanente have published 475+ original research papers.


    With 15 medical centers and 235 medical offices, Kaiser Permanente Southern California includes 7,600 physicians, 27,000 nurses, and 75,000 employees.


    Lead Research/Investigator

    Sara Y Tartof, MD, Ph.D. Department of Research and Evaluation, Kaiser Permanente Southern California, Corresponding Author


    DEFINE_ME

    UCHealth denies kidney transplant to unvaccinated woman in stage 5 renal failure

    Health system reportedly said in August the coronavirus vaccine would not be needed before surgery


    UCHealth denies kidney transplant to unvaccinated woman in stage 5 renal failure | Fox News


    A Colorado woman with stage 5 renal failure is scrambling to find a new hospital to perform a kidney transplant after a health system in the state denied the transplant due to her and her donor being unvaccinated against the coronavirus.


    "Here I am, willing to be a direct donor to her. It does not affect any other patient on the transplant list," Jaimee Fougner, Leilani Lutali’s kidney donor, told CBS4. "How can I sit here and allow them to murder my friend when I’ve got a perfectly good kidney and can save her life?"


    Lutali said she received a letter from Colorado health system UCHealth at the end of September explaining that she and Fougner have 30 days to begin the vaccine process. They would be removed from the kidney transplant list if they refuse the shots.

    "I said I’ll sign a medical waiver. I have to sign a waiver anyway for the transplant itself, releasing them from anything that could possibly go wrong," said Lutali. "It’s surgery, it’s invasive. I sign a waiver for my life. I’m not sure why I can’t sign a waiver for the COVID shot."


    In August, Lutali said the hospital told her that the vaccine would not be a prerequisite to get the surgery

    "At the end of August, they confirmed that there was no COVID shot needed at that time," Lutali told CBS4. "Fast forward to Sept. 28. That’s when I found out. Jamie learned they have this policy around the COVID shot for both for the donor and the recipient."


    NORTH CAROLINA HOSPITAL SYSTEM NOVANT HEALTH TO FIRE 175 EMPLOYEES WHO REFUSED COVID VACCINE MANDATE


    Lutali met Fougner 10 months ago at a Bible study. Lutali said she has not received the vaccine because there are too many unknowns yet, while Fougner has not gotten the shot over religious reasons.

    "It’s your choice on what treatment you have. In Leilani’s case, the choice has been taken from her. Her life has now been held hostage because of this mandate," Fougner added.


    UCHealth said it implemented the vaccine policy for the safety and health of its patients.

    "For transplant patients who contract COVID-19, the mortality rate ranges from about 20% to more than 30%. This shows the extreme risk that COVID-19 poses to transplant recipients after their surgeries," the health system told CBS4. The health system also noted that patients have been required to receive other vaccines, such as for hepatitis B, to help ensure a transplant won’t be rejected.

    Lutali and Fougner are now looking at hospitals outside of Colorado to perform the transplant.

    Quote from Wyttenbach

    Compared this to the same amount of flu vaccine --> > 1000x increase.

    You fail to understand that none of these deaths were caused by the vaccine. Or you do understand this, and you hope the readers here are so stupid they don't know this.


    Quote from Wyttenbach

    And VERS maximally contains 1/10 of all deaths.

    Nonsense. 90% of doctors are not going to violate Federal law by failing to report deaths. Deaths are never unnoticed in the U.S. They are always investigated.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.